The vision: Tailored optical stimulation for the blind

Stimulation of the nervous system with neurotechnology has opened up new avenues for treating human disorders, such as prosthetic arms and legs that restore the sense of touch in amputees, prosthetic fingertips that provide detailed sensory feedback with varying touch…

As novel sights become familiar, different brain rhythms, neurons take over

To focus on what’s new, we disregard what’s not. A new study by researchers at MIT’s Picower Institute for Learning and Memory substantially advances understanding of how a mammalian brain enables this “visual recognition memory.” Dismissing the things in a…

High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease

Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure

Lehigh Engineering PhD students earn prestigious STEM research fellowships from NSF, DoD

Rossin College PhD students Mari-Therese Burton (materials science and engineering) and Nicole Malofsky (bioengineering) have been selected for prestigious national STEM research fellowships. Malofsky, who is advised by Lesley Chow , an assistant professor of bioengineering and materials science and…

Mount Sinai Ophthalmologists Develop New Technique to Assess Progression of Sickle Cell Retinopathy

(New York, NY – May 10, 2021)- Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to…

ARVO Foundation Announces Winner of Oberdorfer Award in Low Vision Research

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Oberdorfer Award in Low Vision Research. The award, which honors Michael D. Oberdorfer, PhD, recognizes a recipient with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Caroline Klaver, MD, PhD of Erasmus Medical Center, Radboud University Medical Center, and the Institute of Molecular and Clinical Ophthalmology Basel (IOB).

Reducing blue light with a new type of LED that won’t keep you up all night

To be more energy efficient, many people have replaced their incandescent lights with light-emitting diode (LED) bulbs. However, those currently on the market emit a lot of blue light, which has been linked to eye troubles and sleep disturbances. Now,…

Better hearing with optical cochlear implants

Understanding spoken words, developing normal speech – cochlear implants enable people with profound hearing impairment to gain a great deal in terms of quality of life. However, background noises are problematic, they significantly compromise the comprehension of speech of people…

Contact lenses poised to detect cancer, treat disease and replace digital screens

Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drug delivery, vision enhancement and mor

NYSCF advances toward a cell therapy for age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD). They will first target dry AMD, a disease that results from the death of…

Scientists develop AI platform to assess blood vessel anomalies and eye disease

An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown University and the Massachusetts Institute of Technology (MIT) has developed an artificial intelligence (AI) platform that could one day be used in a system to assess vascular…